MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Spiral Tunneling Technique for passing electrode lead for Deep Brain Stimulation(DBS) surgery in Parkinson’s disease(PD)

    A. Uppar, D. Srinivas (BANGALORE, India)

    Objective: To compare the conventional “Twist & Anti-Twist” technique and “Spiral Tunnelling Technique”(STT) for tunnelling the leads for Deep Brain Stimulation surgery in PD. Background:…
  • 2023 International Congress

    Acute-onset parkinsonism secondary to bilateral extrapontine myelinolysis of the basal ganglia: case report

    N. Sarhan (Zagazig, Egypt)

    Objective: Although rapid osmolar correction, mainly in the setting of hyponatremia is the main risk factor of osmotic demyelination syndrome, the pathogenesis of the syndrome…
  • 2023 International Congress

    Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

    Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…
  • 2023 International Congress

    Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine the effect of the serotonin 2A/2C (5-HT2A/2C) receptor inverse agonist nelotanserin on dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset. Background: Nelotanserin is a…
  • 2023 International Congress

    Reaching the hard-to-reach: the representativeness of patients with parkinsonism recruited to the PRIME-UK cross-sectional study

    E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To recruit a more representative population of patients with parkinsonism (PwP) focusing on those often excluded from  research. Background: PwP who are older, living…
  • 2023 International Congress

    An Interesting Case of COVID-19 related Parkinsonism

    P. Bhatia, A. Ata, K. Bailey (Tampa, USA)

    Objective: Virus related Parkinsonism causing encephalitis lethargica has been documented in the literature. The novel Coronavirus (COVID-19) has been linked to a small number of…
  • 2023 International Congress

    A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.

    R. Juraev, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparative analysis of vegetative disorders (VD)  in Parkinson's disease and vascular parkinsonism. Background: Vegetative disorders (VD) are one of the most common nonmotor disorders…
  • 2023 International Congress

    Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

    N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

    Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…
  • 2023 International Congress

    Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.

    A. Elaraby, M. Shaien (Gizah, Egypt)

    Objective: To evaluate the efficacy of transcranial magnetic stimulation with patients with Parkinson diseases. Background: Parkinson's disease is one of the most common causes of…
  • 2023 International Congress

    Asymmetric and profound nigrostriatal dopaminergic dysfunction in Parkinson’s disease with preceding REM sleep behavior disorders

    KA. Woo, HJ. Chang, JY. Joo, JH. Shin, SY. Kim, SM. Lee, BR. Jin, HY. Jeon, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To investigate the differences in the pattern of nigrostriatal and pontine monoaminergic degeneration patients with de novo Parkinson's disease (PD), stratified by the presence…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley